EGFR and pulmonary fibrosis: Dysregulation of the EGFR pathway causes aberrant EGFR signaling, which is associated with the early-stage pathogenesis of respiratory diseases, such as cancer, lung fibrosis, COPD, asthma, and cystic fibrosis [40,41].